RT Journal Article
SR Electronic
T1 Lipid-lowering: Can ezetimibe help close the treatment gap?
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 777
OP 783
VO 70
IS 9
A1 Neal, Ryan C.
A1 Jones, Peter H.
YR 2003
UL http://www.ccjm.org/content/70/9/777.abstract
AB Most patients who should be on lipid-lowering therapy are not receiving it, and most patients who are receiving it are not reaching their appropriate low-density lipoprotein (LDL) goals. This is in part because physicians and patients fear side effects of statins and other lipid-lowering agents. Ezetimibe (Zetia), a new lipid-lowering drug, may help physicians close this “treatment gap” in more patients, especially in combination with a statin.